Literature DB >> 18749328

Seizures from theophylline use.

R G Dellen1.   

Abstract

Entities:  

Year:  1983        PMID: 18749328      PMCID: PMC1021496     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


× No keyword cloud information.
  19 in total

1.  Seizures after aminophylline by suppository.

Authors:  P Parfrey; S J Davies
Journal:  Br Med J       Date:  1979-08-25

2.  Resin hemoperfusion as treatment for theophylline-induced seizures.

Authors:  J A Fleetham; J C Ginsburg; K Nakatsu; R D Wigle; P W Munt
Journal:  Chest       Date:  1979-06       Impact factor: 9.410

3.  Clinical experience with theophylline. Relarionships between dosage, serum concentration, and toxicity.

Authors:  M H Jacobs; R M Senior; G Kessler
Journal:  JAMA       Date:  1976-05-03       Impact factor: 56.272

Review 4.  Clinical pharmacology. Series on pharmacology in practice. 4. Theophylline. Practical application of new knowledge.

Authors:  R G Van Dellen
Journal:  Mayo Clin Proc       Date:  1979-11       Impact factor: 7.616

5.  Asthma--a possible interaction between hydrocortisone and theophylline.

Authors:  N Buchanan; S Hurwitz; P Butler
Journal:  S Afr Med J       Date:  1979-12-29

6.  Cimetidine decreases theophylline clearance.

Authors:  M A Campbell; J R Plachetka; J E Jackson; J F Moon; P R Finley
Journal:  Ann Intern Med       Date:  1981-07       Impact factor: 25.391

7.  Evaluation of "toxic" serum theophylline concentrations.

Authors:  W S Burkle; C J Gwizdala
Journal:  Am J Hosp Pharm       Date:  1981-08

8.  Possible thiabendazole-induced theophylline toxicity.

Authors:  A M Sugar; P J Kearns; A A Haulk; J L Rushing
Journal:  Am Rev Respir Dis       Date:  1980-09

9.  Theophylline-induced seizures in adults. Correlation with serum concentrations.

Authors:  C W Zwillich; F D Sutton; T A Neff; W M Cohn; R A Matthay; M M Weinberger
Journal:  Ann Intern Med       Date:  1975-06       Impact factor: 25.391

10.  Inhibition of theophylline metabolism by long-term allopurinol administration.

Authors:  R L Manfredi; E S Vesell
Journal:  Clin Pharmacol Ther       Date:  1981-02       Impact factor: 6.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.